CA2332733C - Sequences-signal, molecules d'acide nucleique et methode de traitement des caries - Google Patents

Sequences-signal, molecules d'acide nucleique et methode de traitement des caries Download PDF

Info

Publication number
CA2332733C
CA2332733C CA2332733A CA2332733A CA2332733C CA 2332733 C CA2332733 C CA 2332733C CA 2332733 A CA2332733 A CA 2332733A CA 2332733 A CA2332733 A CA 2332733A CA 2332733 C CA2332733 C CA 2332733C
Authority
CA
Canada
Prior art keywords
nucleic acid
csp
lys
leu
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2332733A
Other languages
English (en)
Other versions
CA2332733A1 (fr
Inventor
Dennis G. Cvitkovitch
Peter C. Y. Lau
Yung Hua Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Toronto
Original Assignee
University of Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2302861 external-priority patent/CA2302861A1/fr
Application filed by University of Toronto filed Critical University of Toronto
Priority to CA2332733A priority Critical patent/CA2332733C/fr
Priority to US09/833,017 priority patent/US6923962B2/en
Publication of CA2332733A1 publication Critical patent/CA2332733A1/fr
Application granted granted Critical
Publication of CA2332733C publication Critical patent/CA2332733C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2332733A 2000-04-10 2001-02-20 Sequences-signal, molecules d'acide nucleique et methode de traitement des caries Expired - Fee Related CA2332733C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2332733A CA2332733C (fr) 2000-04-10 2001-02-20 Sequences-signal, molecules d'acide nucleique et methode de traitement des caries
US09/833,017 US6923962B2 (en) 2000-04-10 2001-04-10 Signal peptides, nucleic acid molecules and methods for treatment of caries

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,302,861 2000-04-10
CA 2302861 CA2302861A1 (fr) 2000-04-10 2000-04-10 Molecules d'acide nucleique codant pour des sequences-signal et methode de traitement des caries
CA2332733A CA2332733C (fr) 2000-04-10 2001-02-20 Sequences-signal, molecules d'acide nucleique et methode de traitement des caries

Publications (2)

Publication Number Publication Date
CA2332733A1 CA2332733A1 (fr) 2001-10-10
CA2332733C true CA2332733C (fr) 2012-10-02

Family

ID=25681671

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2332733A Expired - Fee Related CA2332733C (fr) 2000-04-10 2001-02-20 Sequences-signal, molecules d'acide nucleique et methode de traitement des caries

Country Status (1)

Country Link
CA (1) CA2332733C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060903A1 (fr) * 2004-12-06 2006-06-15 Kane Biotech Inc. Molecules d'acides nucleiques, peptides signaux, et procedes de traitement
WO2007053945A1 (fr) * 2005-11-09 2007-05-18 Kane Biotech Inc. Composition antimicrobienne orale comprenant un peptide stimulant les competences
US8389679B2 (en) * 2009-02-05 2013-03-05 The Regents Of The University Of California Targeted antimicrobial moieties
CN113481135B (zh) * 2021-06-22 2023-06-30 深圳职业技术学院 一种基于群体感应系统的变异链球菌的检测方法及其应用

Also Published As

Publication number Publication date
CA2332733A1 (fr) 2001-10-10

Similar Documents

Publication Publication Date Title
US20100016234A1 (en) Signal peptides, nucleic acid molecules and methods for treatment of caries
KR20010032581A (ko) 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
WO1998019689A9 (fr) Nouvelles sequences codantes
CA2426738A1 (fr) Genes streptococciques
US6923962B2 (en) Signal peptides, nucleic acid molecules and methods for treatment of caries
CA2481186C (fr) Bacteries gram negatives attenuees
NZ532297A (en) Virulence genes, proteins, and their use in treating conditions associated with infection by Neisseria or gram-negative bacteria
US8313749B2 (en) P. gingivalis vaccine
CA2332733C (fr) Sequences-signal, molecules d'acide nucleique et methode de traitement des caries
JP4932731B2 (ja) シグナルペプチド、核酸分子及び治療方法
US7556807B2 (en) Signal peptides, nucleic acid molecules and methods for treatment of caries
US20040171020A1 (en) Glanders/meliodosis vaccines
CA2302861A1 (fr) Molecules d'acide nucleique codant pour des sequences-signal et methode de traitement des caries
US20090280141A1 (en) Streptococcal Genes
KR20080052693A (ko) 유전자, 단백질 및 그들의 용도
WO1996040926A2 (fr) Detection de cryptosporicium parvum
JP2000210093A (ja) GidA1
JPH11193298A (ja) 応答レギュレーター
JPH11239489A (ja) dnaG
JP2000197482A (ja) aroC

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190220